Rothwell Figg and Firm Co-Founder E. Anthony Figg Named Finalists for Awards Highlighting Best in Life Sciences Legal Sector

Print PDF Icon

The 2023 LMG Life Sciences Americas Awards, an awards program highlighting the best in the life sciences legal sector, includes Rothwell Figg and firm co-founder E. Anthony Figg ("Tony") in their shortlists. The firm is a finalist for the "Intellectual Property Boutique Firm of the Year" award and Tony is a finalist for "Patent Strategy Attorney of the Year - DC Metro" award. The award winners will be recognized during the annual awards event being held September 7, 2023, in New York.

LMG Life Sciences produces one of the most respected awards programs for life sciences practitioners and firms in the United States, Canada, and Europe. Now in its 11th year, the awards cover four main practice areas: financial & corporate, intellectual property, non-IP litigation, and regulatory. The award results are determined through a rigorous research process involving in-depth firm submissions, practitioner interviews, client feedback, and independent research.

In 2018, Tony was inducted into the LMG Life Sciences Hall of Fame at the 6th annual Life Sciences Awards. He and four other attorneys received this honor for their remarkable careers, dedication to clients, and influence on the industry. Over the course of a legal career spanning five decades, Tony has become one of the leaders of the intellectual property bar. He specializes in intellectual property law, with emphasis on the chemical, pharmaceutical, healthcare, and biotechnology industries. His practice focuses on patent litigation and inter partes matters before a wide range of tribunals, appeals, alternate dispute resolution, patent procurement, intellectual property licensing and related contract matters, opinions, and strategic counseling.

To see the shortlists for the 2023 awards in their entirety, please visit the LMG Life Science website.

Jump to Page

By using this site, you agree to our updated Privacy Policy and our Terms of Use.